The last time this summit convened in 2018, the world was shocked to hear a scientist had created the first gene-edited babies. He was condemned, but gene-editing has continued, with some success.
More than 50 consumer and patient groups want the Biden Administration to aggressively protect Americans from medical bills and debt collectors. The effort follows a KHN/NPR investigation.
The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.
Depending on where they lived, demands for repayment can drain the assets that a patient on Medicaid leaves behind after they die. Iowa aggressively collects "clawback" funds.
Millions of people who depend on the Supplemental Nutrition Assistance Program known as SNAP will see a cut of $90 a month or more. Some recipients say it will make it harder to buy healthy food.
Some doctors in Texas are so worried about the abortion bans, they hint to patients with pregnancy complications, "I've heard traveling to Colorado is really nice this time of year."
People leaving jail or prison are at extremely high risk of hospitalization and death, and policymakers from deep blue California to solidly red Utah think bringing Medicaid behind bars could help.
The U.S. faces a shortfall of about 450,000 nurses and 120,000 doctors in the coming years. The Senate's top health committee, led by Sen. Bernie Sanders, is considering bipartisan solutions.
Petitions for compassionate release soared in the pandemic, but federal judges denied most requests. This week officials will review guidelines aimed at freeing imprisoned people who pose no threat.
Politicians are again pointing fingers over cutting Medicare. Any party accused of threatening the program tends to lose elections, but without a bipartisan agreement, seniors stand to lose the most.
Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
Policymakers have long grappled with how to handle experiments that might generate potentially dangerous viruses. Now, officials are considering whether oversight needs to be expanded.
Long criticized as discriminatory, the policy has prevented many gay and bisexual men from donating blood. The Food and Drug Administration revealed a draft of its new approach on Friday.
Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.
